Pegaptanib for Neovascular Age-Related Macular Degeneration.

Evangelos S. Gragoudas, M.D., Anthony P. Adamis, M.D., Emmett T. Cunningham, Jr., M.D., Ph.D., M.P.H., Matthew Feinsid, M.D., and David R. Guyer, M.D., for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group

The New England Journal of Medicine. 2004; 351:2805-16.

2004